封面
市場調查報告書
商品編碼
1771504

美國腎臟保存市場規模、佔有率、趨勢分析報告:按保存解決方案、技術、捐贈者類型、最終用途、細分市場預測,2025-2030 年

U.S. Kidney Preservation Market Size, Share & Trends Analysis Report By Preservation Solution (University of Wisconsin Solution, Celsior Solution), By Technique (Static Cold Storage), By Donor Type, By End Use, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

美國腎臟保存市場的趨勢:

美國腎臟保存市場規模預計在2024年達到2,120萬美元,預計2025年至2030年的複合年成長率為6.97%。市場成長的促進因素包括末期腎功能衰竭(ESRD)以及糖尿病、高血壓等慢性疾病的盛行率上升。腎臟移植需求的不斷成長也推動了市場的成長。常溫機械灌注等保存技術的進步提高了器官在運輸和儲存過程中的存活率。政府支持器官捐贈計畫的措施也進一步推動了市場的發展。

美國腎臟保存市場擴張的主要驅動力是死者捐贈移植數量的持續成長,這增加了對可靠保存解決方案的需求。例如,根據器官取得與移植網路 (OPTN) 的數據,美國死者捐贈移植數量預計將從 2014 年的 12,279 例增加到 2024 年的 22,074 例。最近的趨勢表明,鴉片類藥物相關死亡和捐贈者接受標準的擴大導致死者捐贈數量增加。由於器官獲取組織 (OPO) 優先從具有不同生理特徵的捐贈者(包括患有急性腎損傷 (AKI) 和併發症的捐贈者)獲取腎臟,因此依賴先進的保存技術對於最佳化移植結果至關重要。此外,UNOS 於 2021 年轉向基於距離的腎臟分配政策,擴大了器官分配的地理半徑,進一步強調了延長保存技術的重要性。

同樣,美國的腎臟移植數量也在大幅增加,預計在預測期內這種趨勢仍將持續,從而增加對先進腎臟保存解決方案的需求。

此外,美國腎臟保存市場的成長也受到政府和組織旨在提高腎臟捐贈率的舉措的推動。諸如「推進美國腎臟健康計劃」等聯邦計畫以及醫療保險和醫療補助服務中心 (CMS) 的政策改革,均優先考慮擴大器官移植的可及性,激勵獎勵獲取組織 (OPO) 增加可行腎臟的獲取和利用。

2024年,生命禮物捐贈計畫(Gift of Life Donor Program)協調了947例腎臟移植,位居美國器官採購機構之首,並連續九年保持領先地位。這家總部位於費城的機構正值成立50週年,迄今促成超過21,000例腎臟移植。預計各機構的此類努力將進一步增加美國的腎臟捐贈數量,從而在預測期內推動對器官保存解決方案的需求。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國腎臟保存市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 腎臟保存市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國腎臟保存市場:保存解決方案的估計和趨勢分析

  • 細分儀表板
  • 美國腎臟保存市場趨勢分析(Preservation Solution)
  • 2018-2030 年美國腎臟保存市場規模及趨勢分析(依保存解決方案)
  • 威斯康辛大學(UW)解決方案
  • 組胺酸-色胺酸-酮戊二酸(HTK)溶液
  • Celsior 溶液
  • 高滲透壓檸檬酸腺嘌呤(HC-A)溶液
  • 豪爾赫洛佩茲研究所 (IGL-1) 解決方案
  • 其他

第5章美國腎臟保存市場:技術評估與趨勢分析

  • 細分儀表板
  • 美國腎臟保存市場趨勢分析(按技術)
  • 2018-2030 年美國腎臟保存市場規模及趨勢分析(依技術)
  • 靜態冷藏保管
  • 低溫機械灌注
  • 常溫機械灌注

第6章美國腎臟保存市場:按捐贈者類型進行的估計和趨勢分析

  • 細分儀表板
  • 美國腎臟保存市場(按捐贈者類型)趨勢分析
  • 2018-2030 年美國腎臟保存市場規模及趨勢分析(依捐贈者類型)
  • 標準捐贈者(SCD)
  • 擴展標準捐助者 (ECD)
  • 腦死(DBD)後器官捐贈
  • 循環死亡(DCD)後的器官捐贈
  • 活體捐贈者

第7章美國腎臟保存市場:依最終用途的估計和趨勢分析

  • 細分儀表板
  • 美國腎臟保存市場最終用途趨勢分析
  • 2018-2030 年美國腎臟保存市場規模及趨勢分析(依最終用途)
  • 移植中心/醫院
  • 器官捐贈組織(OPO)
  • 其他

第8章 競爭態勢

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/上市公司
    • TransMedics Inc.
    • XVIVO
    • Bridge to Life Ltd.
    • Paragonix Technologies Inc.
    • OrganOx Limited
    • Organ Recovery Systems
    • Institut Georges Lopez(IGL)
    • Preservation Solutions, Inc.
    • Global Transplant Solutions
    • Essential Pharmaceuticals LLC
Product Code: GVR-4-68040-606-3

U.S. Kidney Preservation Market Trends:

The U.S. kidney preservation market size was estimated at USD 21.2 million in 2024 and is expected to grow at a CAGR of 6.97% from 2025 to 2030. The market growth is driven by several factors, including the rising incidence of end-stage renal disease (ESRD) and chronic conditions such as diabetes and hypertension. The increasing demand for kidney transplants also fuels market growth. Advances in preservation technologies, such as normothermic machine perfusion, enhance organ viability during transportation and storage. Government initiatives supporting organ donation programs further boost the market.

A major driver of the U.S. kidney preservation market's expansion is the consistent rise in deceased donor transplants, which has led to a greater need for reliable preservation solutions. For instance, according to the Organ Procurement & Transplantation Network (OPTN), the deceased donor transplants in the U.S. increased from 12,279 in 2014 to 22,074 in 2024. According to recent trends, the number of deceased donors has increased due to a combination of opioid-related deaths and expanded donor acceptance criteria. As organ procurement organizations (OPOs) prioritize the recovery of kidneys from donors with varying physiological profiles, including those with AKI or comorbidities, reliance on advanced preservation becomes critical to optimize transplant outcomes. Additionally, the 2021 shift to a distance-based kidney allocation policy by UNOS has increased the geographic radius of organ distribution, further intensifying the importance of extended preservation techniques.

Similarly, the number of kidney transplants in the U.S. is witnessing a significant surge, which is expected to continue over the forecast period, thereby increasing the demand for advanced kidney preservation solutions.

Moreover, the growth of the U.S. kidney preservation market is also driven by a rise in government and organizational initiatives aimed at boosting kidney donation rates. Federal programs such as the Advancing American Kidney Health Initiative and policy reforms by the Centers for Medicare & Medicaid Services (CMS) have prioritized expanding access to transplantation by incentivizing organ procurement organizations (OPOs) to increase recovery and utilization of viable kidneys.

In 2024, the Gift of Life Donor Program led U.S. organ procurement organizations by coordinating 947 kidney transplants, marking its ninth consecutive year at the forefront. Celebrating its 50th anniversary, the Philadelphia-based organization has facilitated over 21,000 kidney transplants. Such initiatives by various organizations are further expected to increase the number of kidney donations in the country, thereby driving demand for preservation solutions over the forecast period.

U.S. Kidney Preservation Market Report Segmentation

This report forecasts revenue growth at the country level and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. kidney preservation market report based on preservation solution, technique, donor type, and end use.

  • Preservation Solution Outlook (Revenue, USD Million, 2018 - 2030)
  • University of Wisconsin (UW)
  • Histidine-Tryptophan-Ketoglutarate (HTK) Solution
  • Celsior Solution
  • Hypertonic Citrate Adenine (HC-A) Solution
  • Institute Georges Lopez (IGL-1) Solution
  • Others
  • Technique Outlook (Revenue, USD Million, 2018 - 2030)
  • Static Cold Storage
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion
  • Other
  • Donor Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Standard Criteria Donor (SCD)
  • Expanded Criteria Donor (ECD)
  • Donation after Brain Death (DBD)
  • Donation after Circulatory Death (DCD)
  • Living Donor
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Transplant Centers / Hospitals
  • Organ Procurement Organizations (OPOs)
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Preservation Solution Segment
    • 1.2.2. Technique Segment
    • 1.2.3. Donor Type Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Kidney Preservation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of kidney diseases
      • 3.2.1.2. Growing kidney donations and transplants
      • 3.2.1.3. Growing geriatric population
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of kidney transplantation
  • 3.3. Kidney Preservation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Kidney Preservation Market: Preservation Solution Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Kidney Preservation Market Preservation Solution Movement Analysis
  • 4.3. U.S. Kidney Preservation Market Size & Trend Analysis, by Preservation Solution, 2018 to 2030 (USD Million)
  • 4.4. University of Wisconsin (UW)
    • 4.4.1. University of Wisconsin (UW) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Histidine-Tryptophan-Ketoglutarate (HTK) Solution
    • 4.5.1. Histidine-Tryptophan-Ketoglutarate (HTK) solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Celsior Solution
    • 4.6.1. Celsior Solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7. Hypertonic Citrate Adenine (HC-A) Solution
    • 4.7.1. Hypertonic Citrate Adenine (HC-A) solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.8. Institute Georges Lopez (IGL-1) Solution
    • 4.8.1. Institute Georges Lopez (IGL-1) solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Kidney Preservation Market: Technique Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Kidney Preservation Market Technique Movement Analysis
  • 5.3. U.S. Kidney Preservation Market Size & Trend Analysis, by Technique, 2018 to 2030 (USD Million)
  • 5.4. Static Cold Storage
    • 5.4.1. Static cold storage market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Hypothermic Machine Perfusion
    • 5.5.1. Hypothermic machine perfusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Normothermic Machine Perfusion
    • 5.6.1. Normothermic machine perfusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Kidney Preservation Market: Donor Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Kidney Preservation Market Donor Type Movement Analysis
  • 6.3. U.S. Kidney Preservation Market Size & Trend Analysis, by Donor Type, 2018 to 2030 (USD Million)
  • 6.4. Standard Criteria Donor (SCD)
    • 6.4.1. Standard Criteria Donor (SCD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Expanded Criteria Donor (ECD)
    • 6.5.1. Expanded Criteria Donor (ECD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Donation after Brain Death (DBD)
    • 6.6.1. Donation after Brain Death (DBD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Donation after Circulatory Death (DCD)
    • 6.7.1. Donation after Circulatory Death (DCD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8. Living Donor
    • 6.8.1. Living donor market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Kidney Preservation Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Kidney Preservation Market End Use Movement Analysis
  • 7.3. U.S. Kidney Preservation Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Transplant Centers / Hospitals
    • 7.4.1. Transplant centers / Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Organ Procurement Organizations (OPOs)
    • 7.5.1. Organ Procurement Organizations (OPOs) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. TransMedics Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. XVIVO
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Bridge to Life Ltd.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Paragonix Technologies Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. OrganOx Limited
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Organ Recovery Systems
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Institut Georges Lopez (IGL)
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Preservation Solutions, Inc.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Global Transplant Solutions
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Essential Pharmaceuticals LLC
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. kidney preservation market by preservation solution, 2018 - 2030 (USD Million)
  • Table 4 U.S. kidney preservation market by technique, 2018 - 2030 (USD Million)
  • Table 5 U.S kidney preservation market by donor type, 2018 - 2030 (USD Million)
  • Table 6 U.S kidney preservation market by end use, 2018 - 2030 (USD Million)
  • Table 7 Participant's overview
  • Table 8 Financial performance
  • Table 9 Key companies undergoing expansions
  • Table 10 Key companies undergoing acquisitions
  • Table 11 Key companies undergoing collaborations
  • Table 12 Key companies launching new products
  • Table 13 Key companies undergoing partnerships
  • Table 14 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 U.S. kidney preservation market: Market outlook
  • Fig. 5 U.S. kidney preservation market: Segment outlook
  • Fig. 6 U.S. kidney preservation market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 U.S. kidney preservation market driver impact
  • Fig. 9 U.S. kidney preservation market restraint impact
  • Fig. 10 U.S. kidney preservation market, solution outlook key takeaways (USD Million)
  • Fig. 11 U.S. kidney preservation market solution movement analysis 2024 & 2030 (USD Million)
  • Fig. 12 University of Wisconsin (UW) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Histidine-Tryptophan-Ketoglutarate (HTK) solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Celsior solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Hypertonic citrate adenine (HC-A) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Institut Georges Lopez-1 (IGL-1) solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 U.S. kidney preservation market, technique outlook key takeaways (USD Million)
  • Fig. 19 U.S. kidney preservation market technique movement analysis 2024 & 2030 (USD Million)
  • Fig. 20 Static cold storage market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Hypothermic machine perfusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Normothermic machine perfusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. kidney preservation market, donor type outlook key takeaways (USD Million)
  • Fig. 24 U.S. kidney preservation market donor type movement analysis 2024 & 2030 (USD Million)
  • Fig. 25 Standard Criteria Donor (SCD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Expanded Criteria Donor (ECD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Donation after Brain Death (DBD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Donation after Circulatory Death (DCD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Living donor market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. kidney preservation market, end use outlook key takeaways (USD Million)
  • Fig. 31 U.S. kidney preservation market end use movement analysis 2024 & 2030 (USD Million)
  • Fig. 32 Transplant centers / hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Organ Procurement Organizations (OPOs) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Heat map analysis
  • Fig. 36 Market participant categorization
  • Fig. 37 U.S. kidney preservation market share analysis, 2024
  • Fig. 38 Strategy framework